Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Jazz Pharma Plc (NQ: JAZZ )

183.13 USD -3.29 (-1.76%)
Streaming Delayed Price Updated: 3:49 PM EDT, Jun 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Jazz Pharma Plc

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Jazz Pharmaceuticals and Leading Cancer Organizations Collaborate to Launch First and Only Digital Hub Focused Exclusively on Emotional, Social and Physical Health Needs of Small Cell Lung Cancer Comm
Nothing Small About It (www.nothingsmallaboutit.com) is a support and educational resource center that spotlights and honors the experiences of people living with small cell lung cancer and their loved... 
From PR Newswire
Jazz Pharmaceuticals Presents 18 Abstracts in Sleep Medicine at SLEEP 2021
Jazz shares results from sleep medicine research and the development of novel therapeutic options for people living with sleep disorders 
From PR Newswire
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels
Financialnewsmedia.com News Commentary 
From PR Newswire
Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of GW Pharmaceuticals, PLC In The Southern District Of California
Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Southern District of California, Ziegler v. GW Pharmaceuticals, PLC... 
From PR Newswire
Jazz Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference on June 2, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its senior management team will provide a company overview and business and financial updates at the Jefferies Virtual Healthcare Conference... 
From PR Newswire
This Could Be The Most Exciting Healthcare Development Of The Year
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
This Could Be The Most Exciting Healthcare Development Of The Year
FN Media Group Presents Financialmorningpost.com Market Commentary 
From PR Newswire
Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities
From InvestorBrandNetwork
Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities
- NetworkNewsWire Editorial Coverage 
From PR Newswire
Jazz to Present New Data at ASCO and EHA 2021 Meetings Showcasing Clinical Advances Across Hematology and Oncology Portfolio
Findings continue to demonstrate Jazz's leadership in developing treatments for difficult-to-treat conditions where few options exist 
From PR Newswire
Bionical Emas launches Expanded Access Program for JZP458 - a recombinant Erwinia Asparaginase
Bionical Emas, a global specialist Clinical Research Organization (CRO), has today announced the launch of a U.S. Expanded Access Program for Jazz Pharmaceuticals' investigational therapy JZP458... 
From PR Newswire
Jazz For Life The New Album By Ski Johnson To Release On Friday, May 21
Tags Music Jazzforlife Celebrities
From PRLog
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of... 
From PR Newswire
Jazz Pharmaceuticals to Participate in Three Investor Conferences in May 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its senior management team will provide a company overview and business and financial updates at the following virtual investor... 
From PR Newswire
Jazz Pharmaceuticals Announces First Quarter 2021 Financial Results
Strong Xywav™ Adoption With 3,900 Active Xywav Patients Exiting The First Quarter 
From PR Newswire
Jazz Pharmaceuticals Announces Closing of Senior Secured Notes Offering
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company" or "Jazz") today announced the closing of its previously announced offering (the "Offering") of $1.5 billion in aggregate principal amount of... 
From PR Newswire
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
From GlobeNewswire News Releases
Jazz Pharmaceuticals Prices $1.5 Billion Senior Secured Notes Offering
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company" or "Jazz") today announced the pricing of the previously announced offering (the "Offering") of $1.5 billion in an aggregate principal amount of... 
From PR Newswire
Jazz Pharmaceuticals Announces Proposed Private Offering of Senior Secured Notes
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company") announced today that its wholly owned subsidiary, Jazz Securities Designated Activity Company (the "Issuer"), is commencing a private offering... 
From PR Newswire
Jazz Pharmaceuticals Presents Phase 3 Study Results of Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Adult Patients with Idiopathic Hypersomnia at 2021 American Academy
Xywav demonstrated statistically significant differences in change in Epworth Sleepiness Scale score (p-value <0.0001), Patient Global Impression of Change (p-value <0.0001) and the Idiopathic... 
From PR Newswire
Jazz Pharmaceuticals to Report 2021 First Quarter Financial Results on May 4, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 first quarter financial results on Tuesday, May 4, 2021 after the close of the financial markets. Company management... 
From PR Newswire
Real Brands Inc. (OTC US: RLBD) is a Major Squeeze Candidate in the Rejuvenated CBD Space (NASDAQ: GWPH) (NASDAQ: JAZZ) (NYSEAMERICAN: YCBD) NASDAQ: NEPT) (NYSE: TPB) (OTC US: MRMD)
Tags Network Marketing Barchart
From OTC
Why Real Brands Inc (OTC US: RLBD) is Tailor Made for CBD Boom 2.0 (NASDAQ: GWPH) NASDAQ: JAZZ) (NYSEAMERICAN: YCBD) (NASDAQ: NEPT) (NYSE: TPB) (OTC US: MRMD)
Tags Investment JAZZ CBD
From OTC
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Idiopathic Hyper
Final FDA decision anticipated by August 12 
From PR Newswire
Oyster Point Pharma Announces New Appointment to Board of Directors
George Eliades joins the Board of Directors 
From GlobeNewswire News Releases
Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos® (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyxeos® (daunorubicin and cytarabine) to include a new indication... 
From PR Newswire
Old Dillard Foundation Seeking 100 Voices
Tags Jazz Gospel Arts
From PRLog
Jazz Pharmaceuticals Announces Participation at the 10th Annual J.P. Morgan Napa Valley Forum
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the 10th Annual J.P. Morgan Napa Valley Forum. 
From PR Newswire
Abundance Of New Material Being Released By Rising Singer-Songwriter Vandi Lynnae
Tags Music Indiana Entertainment
From PRLog
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.